Rapid molecular severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing in hospital employees with mild, nonspecific respiratory symptoms facilitates expedient return to work | Zendy

Alyssa Y Castillo | Zendy; Allison Zelikoff | Zendy; Jeannie D. Chan | Zendy; John B. Lynch | Zendy; Chloe BrysonCahn | Zendy

Open Access

Rapid molecular severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing in hospital employees with mild, nonspecific respiratory symptoms facilitates expedient return to work

Author(s) -

Alyssa Y Castillo,

Allison Zelikoff,

Jeannie D. Chan,

John B. Lynch,

Chloe BrysonCahn

Publication year - 2022

Publication title -

infection control and hospital epidemiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.243

H-Index - 138

eISSN - 1559-6834

pISSN - 0899-823X

DOI - 10.1017/ice.2022.24

Subject(s) - medicine , covid-19 , respiratory system , coronavirus , transmission (telecommunications) , respiratory disease , severe acute respiratory syndrome coronavirus , severe acute respiratory syndrome , intensive care medicine , emergency medicine , disease , virology , infectious disease (medical specialty) , lung , engineering , outbreak , electrical engineering

Nonspecific respiratory symptoms overlap with coronavirus disease 2019 (COVID-19). Prompt diagnosis of COVID-19 in hospital employees is crucial to prevent nosocomial transmission. Rapid molecular SARS-CoV-2 testing was performed for 115 symptomatic employees. The case positivity rate was 2.6%. Employees with negative tests returned to work after 80 (±28) minutes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research